Frequently Asked Questions

TICRO Bioservices, an affiliate of the Trudeau Institute, is a specialty contract research organization delivering a comprehensive range of preclinical research services for biopharma, diagnostic companies, and academic/government laboratories focused on immunology and infectious disease drug discovery and development.

TICRO has proven expertise in performing preclinical in vivo studies utilizing small animal models relevant to evaluating potential therapeutics, infectious disease pathogenesis and determination of immune responses to infection.

Customers can anticipate clear communication, expert consult and well-defined project deliverables and timelines from the TICRO Team. We are invested in our customer’s success and aim to engage our customers using a partnered research approach rather than a transactional mindset.

Yes, if a novel model or system is required to advance your research program, TICRO can work with you on model development. Please contact us for a consult today.

TICRO leverages a robust, small animal platform comprised of mice, ferrets and hamsters. This platform is ideal for evaluating pathogenesis, host factors, transmission and pre-clinical efficacy of candidate therapeutics and vaccines.

We remain open to collaborations with researchers where interests and capabilities align. Please contact us regarding your collaboration idea today.

Yes, commonly used in vitro assays are available as part of TICRO’s standard catalog of offerings and can be added to any study design. If a required assay is not listed, please feel free to contact us and inquire regarding assay development.

Please contact us with any additional questions.